Broad and DuPont yield CRISPR licensing deal in agriculture

The Broad Institute of Harvard and MIT has signed a patent licensing deal with DuPont Pioneer to provide CRISPR/Cas9 technology to agricultural researchers and producers.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

DowDuPont names three new divisions

1 March 2018 DowDuPont, a specialist in agriculture, materials science and speciality products, has revealed the names of three independent companies that it intends on creating.

Americas

CRISPR patent row not over yet, say lawyers

17 February 2017 Although the Patent Trial and Appeal Board gave a win to The Broad Institute of Harvard and MIT in the CRISPR patent conflict against the University of California, Berkeley and the University of Vienna, lawyers say the dispute may still not be resolved.

Americas

CRISPR dispute likely to continue in federal courts

8 December 2016 Following the CRISPR/Cas9 patent hearing on December 6 between The Broad Institute and University of California, Berkeley, it is very unlikely that the case will end at the US Patent and Trademark Office, according to one lawyer.

More features

Killing the golden goose of US drug innovation (Part II): Drug pricing myths

Former pharma GC brings in-house perspective to McGuireWoods

Sandoz eyes US biosimilar launch as Regeneron settles

Killing the golden goose of US drug innovation (Part I): Follow the money

Buchalter brings in new partner to head up medtech

Trump’s march-in rights threat: Why pharma is rethinking collaborations

UK gets new IP minister following cabinet reshuffle

Barnes & Thornburg reveals five new IP leaders

Broad and DuPont yield CRISPR licensing deal in agriculture

More on this story

Editor's picks

Editor's picks

More features